Medicine details

ImageSolone 5
NameSolone 5
DosageTablet
Generic NamePrednisolone
Classes Dermatological/Topical Agent
Ophthalmic Preparation
Hormonal Agent
Steroid
Glucocorticoid
Diseases Adrenocortical Deficiency
Allergy
Arthritis
Asthma
Inflammatory Disease
Keratitis
Leukemia
Lupus
Psoriasis
Ulcerative Colitis
CompanyACI Limited

Drug Package Details

Strength5 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack100
Price per pack172.00
Cost per pack151.36
Package unit10 tabs strip
Price per unit1.72
Cost per unit1.51
Discount0
Coupon
Remarks

Prednisolone

Prednisolone belongs to a class of drugs, called the glucocorticoids. It is a synthetic glucocorticoid. The synthetic analogs are largely employed for anti-inflammatory actions in a variety of organ system illnesses. Glucocorticoids have a wide range of metabolic consequences. Furthermore, they alter the immune system's reaction to a variety of stimuli.

Prednisolone ophthalmic suspension is indicated for steroid responsive inflammatory conditions such as-

  • allergic conjunctivitis
  • acne
  • superficial punctate keratitis
  • herpes zoster keratitis
  • iritis
  • eye irritation
  • cyclitis, selected infective conjunctivitides
  • corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies
  • Two drops applied topically to the eye(s) four times per day. Anti-infective agents must be used concurrently in cases of bacterial infections. It is critical not to discontinue therapy too soon. If the patient's signs and symptoms do not improve after two days, he or she should be re-evaluated.
  • The dosing of Prednisolone suspension may be reduced, but caution should be exercised to avoid premature discontinuation of therapy. Withdrawing treatment from chronic conditions should be done gradually by reducing the frequency of applications.

 Adverse reactions associated with prednisolone, in decreasing order of frequency-

  • Elevation of intraocular pressure
  • Glaucoma
  • Optic nerve damage
  • Posterior subcapsular cataract formation
  • Delayed wound healing
  • A physician should write the initial prescription and renew the medication order only after examining the patient under magnification, such as slit lamp bio-microscopy and, if necessary, fluorescein staining.
  • If the patient's signs and symptoms do not improve after two days, he or she should be re-evaluated.
  • Because fungal infections of the cornea are especially prone to developing concurrently with long-term local corticosteroid applications, fungal invasion should be suspected in any persistent corneal ulceration where a corticosteroid has been or is being used. When necessary, fungal cultures should be obtained.
  • If this product is used for more than 10 days, the intraocular pressure should be monitored.
  • If the inflammation or pain lasts more than 48 hours or worsens, the patient should be advised to stop taking the medication and consult a doctor.

Contraindication

Contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of the medication.

There is no known contraindications of the medication in terms of food and drinks.

Prednisolone ophthalmic suspension is contraindicated in the majority of viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, as well as mycobacterial eye infection and fungal diseases of ocular structures.